RT Journal Article
SR Electronic
T1 Potential Impacts of Mass Nutritional Supplementation on Dynamics of Measles: A Simulation Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.10.21263402
DO 10.1101/2021.09.10.21263402
A1 Noori, Navideh
A1 Skrip, Laura A.
A1 Oron, Assaf P.
A1 McCarthy, Kevin A.
A1 Althouse, Benjamin M.
A1 Trehan, Indi
A1 Phelan, Kevin P.Q.
YR 2021
UL http://medrxiv.org/content/early/2021/09/15/2021.09.10.21263402.abstract
AB The bidirectional interaction between undernutrition and infection can be devastating to child health. Nutritional deficiencies stunt growth, impair immunity, increase susceptibility to both infection and more severe outcomes from common infections. Simultaneously, infections compound undernutrition by increasing metabolic demand, reducing food intake, and impairing nutrient absorption. Treatment of acute malnutrition (wasting) can reverse at least some of its deleterious effects and reduce susceptibility to, and transmission of, infectious diseases. Nutrition-specific approaches may be packaged with other interventions, including immunization, to support overall child health. To understand how mass nutritional supplementation, treatment of wasting, and vaccination affect the dynamics of a vaccine-preventable infection, we developed a population-level, compartmental model of measles transmission of children aged 6-23 months old, stratified by nutrition status. We simulated a range of scenarios to assess the potential reductions in measles infection and mortality associated with targeted therapeutic feeding for children who are wasted and with a mass supplementation intervention. Nutrition interventions were assumed to reduce susceptibility to measles-related death and to increase engagement with the health sector, leading to increased vaccination rates. We found that if all wasted children receive therapeutic feeding, and if this leads to an increase in measles vaccination uptake, up to 12%, 20%, and 23% reductions in measles infections, measles-attributable mortality, and overall mortality among wasted children, respectively, could be averted. Combination of wasting treatment and mass supplementation coverage followed by an increase in vaccination coverage of non-wasted children from a baseline of 75% to 85%, leads to a 64-66% reduction in measles infection and mortality and 27% reduction in overall mortality among wasted children, compared with the wasting treatment alone. Our work highlights the synergistic benefits that may be achieved by leveraging mass nutritional supplementation as a touch point with the health system, to increase rates of vaccination in order to improve child survival beyond what would be expected from the additive benefits of each intervention.Significance Statement The pathways by which undernutrition and infection interact have not been fully disentangled. Undernourished children may be more susceptible to infection and at increased risk for infectious disease complications. Infection also can interfere with nutrition intake or retention. Nutrition-based interventions may have indirect benefits on reducing infectious disease burden by reducing susceptibility through multiple routes. One of these is enhancing engagement with the health sector, thereby leading to adoption of other essential services such as vaccination. Here we quantify the association between undernutrition and a vaccine-preventable disease by developing a mathematical model of measles transmission which accounts for childhood nutritional and vaccination statuses. Our results show that mass nutritional supplementation has a strong effect in reducing the burden of measles and undernutrition, compared with wasting treatment only. Our work may elevate the potential role of nutritional supplementation in infection prevention, and encourage more targeted data collection around the effectiveness of packaged care in optimizing child development and growth.Competing Interest StatementKevin P.Q. Phelan, The Alliance for International Medical Action (ALIMA) serves on the Social Purposes Advisory Commission of Nutriset, a main producer of lipid-based nutrient supplement products. Other authors declare no conflict of interest.Funding StatementThe funders had no role in study design, data collection, data analysis, the decision to publish, or preparation of the manuscript. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of their respective employers or funders.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Non applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no data underlying this work.